Skip to main content
Erschienen in: Lung 6/2010

01.12.2010

Usefulness of Triglyceride Levels in Pleural Fluid

verfasst von: Luis Valdés, Ma. Esther San José, Antonio Pose, Juan Carlos Estévez, Francisco J. González-Barcala, José M. Álvarez-Dobaño, Richard W. Light

Erschienen in: Lung | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

The determination of pleural fluid triglycerides (PF-TRIG) is useful in the diagnosis of chylothorax, but its diagnostic value for other causes of pleural effusions is unknown. The aim of this study was to evaluate the usefulness of PF-TRIG in the diagnosis of other pleural effusions and investigate the origin of their increase in these fluids. We studied 390 pleural effusions (75 tuberculous, 107 neoplastic, 39 parapneumonic, 30 miscellaneous, 42 idiopathic, and 97 transudates). The correlation was analyzed with the PF-TRIG values as the dependent variable and serum triglycerides (S-TRIG) and the pleural fluid/serum protein ratio (PF/S PROT ratio) as independent variables. The PF-TRIG was significantly higher in exudates. The sensitivity of PF-TRIG for identifying exudates was 84.3%, specificity 61.9%. The correlation between PF-TRIG and S-TRIG was significant in the exudates and in the total pleural effusions. There was a significant correlation between PF-TRIG and S-TRIG and capillary permeability, which worsened when looking at the transudates and exudates separately. No correlations were found between the PF-TRIG and the number of red cells and white cells in any of the groups. Except for diagnosing a chylothorax, the determination of triglycerides in pleural fluid does not appear to be justified. The cause of the increase in PF-TRIG in exudates could not be established because the correlations obtained were insufficient to be able to predict PF-TRIG values from their serum values and the measurement of capillary permeability.
Literatur
1.
Zurück zum Zitat Collins TR, Sahn SA (1987) Thoracentesis: complications, patient experience and diagnostic value. Chest 91:817–822CrossRefPubMed Collins TR, Sahn SA (1987) Thoracentesis: complications, patient experience and diagnostic value. Chest 91:817–822CrossRefPubMed
2.
Zurück zum Zitat Sahn SA (1987) Pleural fluid analysis: narrowing the differential diagnosis. Semin Respir Med 9:22–29CrossRef Sahn SA (1987) Pleural fluid analysis: narrowing the differential diagnosis. Semin Respir Med 9:22–29CrossRef
3.
Zurück zum Zitat Sahn SA (1988) The pleura. State of the art. Am Rev Respir Dis 138:184–234PubMed Sahn SA (1988) The pleura. State of the art. Am Rev Respir Dis 138:184–234PubMed
4.
Zurück zum Zitat Gopi A, Madhavan SM, Sharma SK, Sahn SA (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131:880–889CrossRefPubMed Gopi A, Madhavan SM, Sharma SK, Sahn SA (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131:880–889CrossRefPubMed
5.
Zurück zum Zitat Valdés L, Álvarez D, San José E, Juanatey JR, Pose A, Valle JM, Salgueiro M, Suarez JR (1995) Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax 50:593–594CrossRef Valdés L, Álvarez D, San José E, Juanatey JR, Pose A, Valle JM, Salgueiro M, Suarez JR (1995) Value of adenosine deaminase in the diagnosis of tuberculous pleural effusions in young patients in a region of high prevalence of tuberculosis. Thorax 50:593–594CrossRef
6.
Zurück zum Zitat Valdés L, Álvarez D, Valle JM, Pose A, San José E (1996) The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 109:158–162CrossRefPubMed Valdés L, Álvarez D, Valle JM, Pose A, San José E (1996) The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 109:158–162CrossRefPubMed
7.
Zurück zum Zitat Hamm H, Pfalzer B, Fabel H (1991) Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration 58:294–300CrossRefPubMed Hamm H, Pfalzer B, Fabel H (1991) Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis and diagnosis. Respiration 58:294–300CrossRefPubMed
8.
Zurück zum Zitat Valdés L, Pose A, Suárez J, Gonzalez-Juanatey JR, Sarandeses A, San José E, Alvarez Dobaña JM, Salgueiro M, Rodríguez Suárez JR (1991) Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest 99:1097–1102CrossRefPubMed Valdés L, Pose A, Suárez J, Gonzalez-Juanatey JR, Sarandeses A, San José E, Alvarez Dobaña JM, Salgueiro M, Rodríguez Suárez JR (1991) Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest 99:1097–1102CrossRefPubMed
9.
Zurück zum Zitat Costa M, Quiroga T, Cruz E (1995) Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest 108:1260–1263CrossRefPubMed Costa M, Quiroga T, Cruz E (1995) Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest 108:1260–1263CrossRefPubMed
10.
Zurück zum Zitat Valdés L, Pose A, San José E, Suarez J, Penela P, Valle JM, Alvarez D (1998) Diagnostic value of cholesterol in pleural fluids. Eur J Intern Med 9:157–164 Valdés L, Pose A, San José E, Suarez J, Penela P, Valle JM, Alvarez D (1998) Diagnostic value of cholesterol in pleural fluids. Eur J Intern Med 9:157–164
11.
Zurück zum Zitat Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55:700–704PubMed
12.
Zurück zum Zitat Sahn SA, Heffner JE (2003) Pleural fluid analysis. In: Light RW, Lee YCG (eds) Textbook of pleural fluids. Arnold, London, pp 191–209 Sahn SA, Heffner JE (2003) Pleural fluid analysis. In: Light RW, Lee YCG (eds) Textbook of pleural fluids. Arnold, London, pp 191–209
13.
Zurück zum Zitat Mahley RW, Weisgraber KW, Farese RV Jr (1998) Disorders of lipid metabolism. In: Williams RH (ed) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1099–1119 Mahley RW, Weisgraber KW, Farese RV Jr (1998) Disorders of lipid metabolism. In: Williams RH (ed) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1099–1119
14.
Zurück zum Zitat Meisel S, Shamiss A, Thaler M, Nussinovitch N, Rosenthal T (1990) Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest 98:141–144CrossRefPubMed Meisel S, Shamiss A, Thaler M, Nussinovitch N, Rosenthal T (1990) Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest 98:141–144CrossRefPubMed
15.
Zurück zum Zitat Roth BJ, O’Meara TF, Cragum WH (1990) The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 98:546–549CrossRefPubMed Roth BJ, O’Meara TF, Cragum WH (1990) The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 98:546–549CrossRefPubMed
16.
Zurück zum Zitat Heffner JE, Brown LK, Barbieri C (1997) Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 111:970–979CrossRefPubMed Heffner JE, Brown LK, Barbieri C (1997) Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest 111:970–979CrossRefPubMed
17.
Zurück zum Zitat Romero S, Candela A, Martin C, Hernández L, Trigo C, Gil J (1993) Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 104:399–404CrossRefPubMed Romero S, Candela A, Martin C, Hernández L, Trigo C, Gil J (1993) Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 104:399–404CrossRefPubMed
18.
Zurück zum Zitat Burgess L, Maritz FJ, Taljaard JJF (1995) Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 107:1604–1609CrossRefPubMed Burgess L, Maritz FJ, Taljaard JJF (1995) Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 107:1604–1609CrossRefPubMed
19.
Zurück zum Zitat Antony VB, Holm KA (1995) Testing the waters. Differentiating transudates from exudates. Chest 108:1191–1192CrossRefPubMed Antony VB, Holm KA (1995) Testing the waters. Differentiating transudates from exudates. Chest 108:1191–1192CrossRefPubMed
20.
Zurück zum Zitat Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133CrossRefPubMed Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84:129–133CrossRefPubMed
21.
Zurück zum Zitat Sahn SA (1995) Diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 6:269–278CrossRef Sahn SA (1995) Diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 6:269–278CrossRef
22.
Zurück zum Zitat Vaz MA, Teixeira LR, Vargas FS, Carmo AO, Antonangelo L, Onishi R, Light RW (2001) Relationship between pleural fluid and serum cholesterol levels. Chest 119:204–210CrossRefPubMed Vaz MA, Teixeira LR, Vargas FS, Carmo AO, Antonangelo L, Onishi R, Light RW (2001) Relationship between pleural fluid and serum cholesterol levels. Chest 119:204–210CrossRefPubMed
23.
Zurück zum Zitat Valdés L, San-José E, Estévez JC, González-Barcala FJ, Álvarez-Dobaño JM, Golpe A, Valle JM, Penela P, Vizcaíno L, Pose A (2010) Cholesterol in pleural exudates depends mainly on increased capillary permeability. Transl Res 155:178–184CrossRefPubMed Valdés L, San-José E, Estévez JC, González-Barcala FJ, Álvarez-Dobaño JM, Golpe A, Valle JM, Penela P, Vizcaíno L, Pose A (2010) Cholesterol in pleural exudates depends mainly on increased capillary permeability. Transl Res 155:178–184CrossRefPubMed
24.
Zurück zum Zitat Hillerdal G (2003) Effusions from lymphatic disruptions. In: Light RW, Lee YCG (eds) Textbook of pleural diseases. Arnold, London, pp 362–369 Hillerdal G (2003) Effusions from lymphatic disruptions. In: Light RW, Lee YCG (eds) Textbook of pleural diseases. Arnold, London, pp 362–369
Metadaten
Titel
Usefulness of Triglyceride Levels in Pleural Fluid
verfasst von
Luis Valdés
Ma. Esther San José
Antonio Pose
Juan Carlos Estévez
Francisco J. González-Barcala
José M. Álvarez-Dobaño
Richard W. Light
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 6/2010
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9261-4

Weitere Artikel der Ausgabe 6/2010

Lung 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.